Schedule 13G ownership disclosure
KEZAR LIFE SCIENCES INC
Security class unavailable · CUSIP: 49372L100
Event date: 2019-01-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-023303
- Form type
- SC 13G
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Jan 31, 2019
- Reporting period
- Jan 28, 2019
- Description
- Schedule 13G beneficial ownership